Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System
Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper sho...
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2005-02, Vol.90 (2), p.992-1000 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1000 |
---|---|
container_issue | 2 |
container_start_page | 992 |
container_title | The journal of clinical endocrinology and metabolism |
container_volume | 90 |
creator | Carrillo-Vico, Antonio Lardone, Patricia J. Fernández-Santos, José M. Martín-Lacave, Inés Calvo, Juan R. Karasek, Michal Guerrero, Juan M. |
description | Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system. |
doi_str_mv | 10.1210/jc.2004-1429 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67410847</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67410847</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</originalsourceid><addsrcrecordid>eNptkNGL1DAQxoMo3rr65rP0RZ_MXZImafsox-ktrAiegm8hzU7d7qXJmrS31L_eWXfhEAwkwzfzy2TyEfKas0suOLvauUvBmKRciuYJWfBGKlrxpnpKFowJTptK_LggL3LeMcalVOVzcsGV0gLVghxup8GGYj0P-2108wj0bg7jFnL_GzbFZ_B2jKEPxSoXq_AQ_QNmUSJRfIWfE5b7GIrY_c2swgjJw3TfByqu_lFIO9iPMRV3cx5heEmeddZneHWOS_L9482361u6_vJpdf1hTZ2UuqINcK4400pjrKBl1lUtK8tOdnWtWy0kF13XNDWzUGtWa8cF1LJuAStSi3JJ3p367lP8NUEezdBnB97bAHHKRleSs1pWCL4_gS7FnBN0Zp_6wabZcGaORpudM0ejzdFoxN-c-07tAJtH-OwsAm_PgM3O-i7Z4Pr8yGklKoU_WRJ54g7Ro1_53k8HSGYL1o9bw3ChDzXFlxXDg1Hc6jhueboGYRNd6gPsE-RsdnFKAQ39_9R_AEPZphU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67410847</pqid></control><display><type>article</type><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><source>MEDLINE</source><source>Oxford University Press Journals All Titles (1996-Current)</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</creator><creatorcontrib>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</creatorcontrib><description>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</description><identifier>ISSN: 0021-972X</identifier><identifier>EISSN: 1945-7197</identifier><identifier>DOI: 10.1210/jc.2004-1429</identifier><identifier>PMID: 15562014</identifier><identifier>CODEN: JCEMAZ</identifier><language>eng</language><publisher>Bethesda, MD: Endocrine Society</publisher><subject>Adult ; Biological and medical sciences ; Cells, Cultured ; Endocrinopathies ; Fundamental and applied biological sciences. Psychology ; Gene Expression Regulation - immunology ; Humans ; Interleukin-2 - genetics ; Interleukin-2 - physiology ; Lymphocytes - drug effects ; Lymphocytes - immunology ; Medical sciences ; Melatonin - biosynthesis ; Middle Aged ; Receptors, Interleukin-2 - genetics ; Receptors, Interleukin-2 - physiology ; Receptors, Melatonin - antagonists & inhibitors ; Receptors, Melatonin - physiology ; Tryptamines - pharmacology ; Vertebrates: endocrinology</subject><ispartof>The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.992-1000</ispartof><rights>Copyright © 2005 by The Endocrine Society</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</citedby><cites>FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=16527503$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15562014$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Carrillo-Vico, Antonio</creatorcontrib><creatorcontrib>Lardone, Patricia J.</creatorcontrib><creatorcontrib>Fernández-Santos, José M.</creatorcontrib><creatorcontrib>Martín-Lacave, Inés</creatorcontrib><creatorcontrib>Calvo, Juan R.</creatorcontrib><creatorcontrib>Karasek, Michal</creatorcontrib><creatorcontrib>Guerrero, Juan M.</creatorcontrib><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><title>The journal of clinical endocrinology and metabolism</title><addtitle>J Clin Endocrinol Metab</addtitle><description>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</description><subject>Adult</subject><subject>Biological and medical sciences</subject><subject>Cells, Cultured</subject><subject>Endocrinopathies</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gene Expression Regulation - immunology</subject><subject>Humans</subject><subject>Interleukin-2 - genetics</subject><subject>Interleukin-2 - physiology</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - immunology</subject><subject>Medical sciences</subject><subject>Melatonin - biosynthesis</subject><subject>Middle Aged</subject><subject>Receptors, Interleukin-2 - genetics</subject><subject>Receptors, Interleukin-2 - physiology</subject><subject>Receptors, Melatonin - antagonists & inhibitors</subject><subject>Receptors, Melatonin - physiology</subject><subject>Tryptamines - pharmacology</subject><subject>Vertebrates: endocrinology</subject><issn>0021-972X</issn><issn>1945-7197</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNptkNGL1DAQxoMo3rr65rP0RZ_MXZImafsox-ktrAiegm8hzU7d7qXJmrS31L_eWXfhEAwkwzfzy2TyEfKas0suOLvauUvBmKRciuYJWfBGKlrxpnpKFowJTptK_LggL3LeMcalVOVzcsGV0gLVghxup8GGYj0P-2108wj0bg7jFnL_GzbFZ_B2jKEPxSoXq_AQ_QNmUSJRfIWfE5b7GIrY_c2swgjJw3TfByqu_lFIO9iPMRV3cx5heEmeddZneHWOS_L9482361u6_vJpdf1hTZ2UuqINcK4400pjrKBl1lUtK8tOdnWtWy0kF13XNDWzUGtWa8cF1LJuAStSi3JJ3p367lP8NUEezdBnB97bAHHKRleSs1pWCL4_gS7FnBN0Zp_6wabZcGaORpudM0ejzdFoxN-c-07tAJtH-OwsAm_PgM3O-i7Z4Pr8yGklKoU_WRJ54g7Ro1_53k8HSGYL1o9bw3ChDzXFlxXDg1Hc6jhueboGYRNd6gPsE-RsdnFKAQ39_9R_AEPZphU</recordid><startdate>200502</startdate><enddate>200502</enddate><creator>Carrillo-Vico, Antonio</creator><creator>Lardone, Patricia J.</creator><creator>Fernández-Santos, José M.</creator><creator>Martín-Lacave, Inés</creator><creator>Calvo, Juan R.</creator><creator>Karasek, Michal</creator><creator>Guerrero, Juan M.</creator><general>Endocrine Society</general><general>Copyright by The Endocrine Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200502</creationdate><title>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</title><author>Carrillo-Vico, Antonio ; Lardone, Patricia J. ; Fernández-Santos, José M. ; Martín-Lacave, Inés ; Calvo, Juan R. ; Karasek, Michal ; Guerrero, Juan M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4467-9e115106561157eb0ac7b033f4f886b62412ff9980ae86086c12e848be2414623</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Biological and medical sciences</topic><topic>Cells, Cultured</topic><topic>Endocrinopathies</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gene Expression Regulation - immunology</topic><topic>Humans</topic><topic>Interleukin-2 - genetics</topic><topic>Interleukin-2 - physiology</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - immunology</topic><topic>Medical sciences</topic><topic>Melatonin - biosynthesis</topic><topic>Middle Aged</topic><topic>Receptors, Interleukin-2 - genetics</topic><topic>Receptors, Interleukin-2 - physiology</topic><topic>Receptors, Melatonin - antagonists & inhibitors</topic><topic>Receptors, Melatonin - physiology</topic><topic>Tryptamines - pharmacology</topic><topic>Vertebrates: endocrinology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Carrillo-Vico, Antonio</creatorcontrib><creatorcontrib>Lardone, Patricia J.</creatorcontrib><creatorcontrib>Fernández-Santos, José M.</creatorcontrib><creatorcontrib>Martín-Lacave, Inés</creatorcontrib><creatorcontrib>Calvo, Juan R.</creatorcontrib><creatorcontrib>Karasek, Michal</creatorcontrib><creatorcontrib>Guerrero, Juan M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The journal of clinical endocrinology and metabolism</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Carrillo-Vico, Antonio</au><au>Lardone, Patricia J.</au><au>Fernández-Santos, José M.</au><au>Martín-Lacave, Inés</au><au>Calvo, Juan R.</au><au>Karasek, Michal</au><au>Guerrero, Juan M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System</atitle><jtitle>The journal of clinical endocrinology and metabolism</jtitle><addtitle>J Clin Endocrinol Metab</addtitle><date>2005-02</date><risdate>2005</risdate><volume>90</volume><issue>2</issue><spage>992</spage><epage>1000</epage><pages>992-1000</pages><issn>0021-972X</issn><eissn>1945-7197</eissn><coden>JCEMAZ</coden><abstract>Since melatonin was first isolated in 1958 up to the last few years, this substance was considered a hormone exclusive to the pineal gland. Although melatonin has lately been identified in a large number of extrapineal sites, its potential biological actions have not yet been studied. This paper shows that human lymphocyte-synthesized melatonin plays a crucial role modulating IL-2/IL-2 receptor system because when blocking melatonin biosynthesis by the tryptophan hydroxylase inhibitor, parachlorophenylalanine, both IL-2 and IL-2 receptor levels fell, restoring them by adding exogenous melatonin. Moreover, we demonstrated that this endogenous melatonin interfered with the exogenous melatonin effect on IL-2 production. Melatonin exerted these effects by a receptor-mediated action mechanism because both IL-2 and IL-2 receptor expressions significantly decreased when lymphocytes were incubated in the presence of the specific membrane and/or nuclear melatonin receptor antagonists, luzindole, and/or CGP 55644, respectively. Finally, we made the real significance of the membrane melatonin receptors in this process clear, so prostaglandin E2-induced inhibition on IL-2 production increased when we blocked the membrane receptors using luzindole. In conclusion, these data show that endogenous melatonin is an essential part for an accurate response of human lymphocytes through the modulation of IL-2/IL-2 receptor system.</abstract><cop>Bethesda, MD</cop><pub>Endocrine Society</pub><pmid>15562014</pmid><doi>10.1210/jc.2004-1429</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0021-972X |
ispartof | The journal of clinical endocrinology and metabolism, 2005-02, Vol.90 (2), p.992-1000 |
issn | 0021-972X 1945-7197 |
language | eng |
recordid | cdi_proquest_miscellaneous_67410847 |
source | MEDLINE; Oxford University Press Journals All Titles (1996-Current); EZB-FREE-00999 freely available EZB journals |
subjects | Adult Biological and medical sciences Cells, Cultured Endocrinopathies Fundamental and applied biological sciences. Psychology Gene Expression Regulation - immunology Humans Interleukin-2 - genetics Interleukin-2 - physiology Lymphocytes - drug effects Lymphocytes - immunology Medical sciences Melatonin - biosynthesis Middle Aged Receptors, Interleukin-2 - genetics Receptors, Interleukin-2 - physiology Receptors, Melatonin - antagonists & inhibitors Receptors, Melatonin - physiology Tryptamines - pharmacology Vertebrates: endocrinology |
title | Human Lymphocyte-Synthesized Melatonin Is Involved in the Regulation of the Interleukin-2/Interleukin-2 Receptor System |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-12T15%3A08%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Lymphocyte-Synthesized%20Melatonin%20Is%20Involved%20in%20the%20Regulation%20of%20the%20Interleukin-2/Interleukin-2%20Receptor%20System&rft.jtitle=The%20journal%20of%20clinical%20endocrinology%20and%20metabolism&rft.au=Carrillo-Vico,%20Antonio&rft.date=2005-02&rft.volume=90&rft.issue=2&rft.spage=992&rft.epage=1000&rft.pages=992-1000&rft.issn=0021-972X&rft.eissn=1945-7197&rft.coden=JCEMAZ&rft_id=info:doi/10.1210/jc.2004-1429&rft_dat=%3Cproquest_cross%3E67410847%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67410847&rft_id=info:pmid/15562014&rfr_iscdi=true |